|
A-431
|
IC50 |
3 x 10 -1 μg/mL
Compound: 38
|
Inhibition of EGFR in human A431 cells
Inhibition of EGFR in human A431 cells
|
[PMID: 1479375]
|
|
A549
|
EC50 |
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 12027739]
|
|
B16-BL6
|
EC50 |
|
Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay
Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay
|
[PMID: 12027739]
|
|
BALB/3T3
|
IC50 |
|
Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
|
[PMID: 10096863]
|
|
C2C12
|
IC50 |
|
Cytotoxicity against mouse C2C12 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against mouse C2C12 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 33412152]
|
|
C8166
|
CC50 |
|
Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 24794743]
|
|
C8166
|
EC50 |
|
Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
|
[PMID: 24794743]
|
|
Col2
|
ED50 |
19.3 μg/mL
Compound: apigenin
|
Cytotoxicity against human Col2 cells
Cytotoxicity against human Col2 cells
|
[PMID: 7931367]
|
|
DLD-1
|
IC50 |
|
Antiproliferative activity against human DLD-1 cells assessed as cell growth inhibition
Antiproliferative activity against human DLD-1 cells assessed as cell growth inhibition
|
[PMID: 34355179]
|
|
H9
|
EC50 |
|
Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
|
[PMID: 8158164]
|
|
H9
|
EC50 |
|
Inhibitory activity against HIV-1 IIIB replication in H9 cell line
Inhibitory activity against HIV-1 IIIB replication in H9 cell line
|
10.1016/0960-894X(94)80015-4
|
|
H9
|
IC50 |
|
Cytotoxicity against human H9 cells after 3 days
Cytotoxicity against human H9 cells after 3 days
|
[PMID: 8158164]
|
|
H9
|
IC50 |
|
Inhibitory activity against H9 cells uninfected with HIV-1
Inhibitory activity against H9 cells uninfected with HIV-1
|
10.1016/0960-894X(94)80015-4
|
|
HCT-116
|
EC50 |
23.8 μM
Compound: Apigenin
|
Cytotoxicity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 26529431]
|
|
HCT-116
|
IC50 |
|
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition
|
[PMID: 34355179]
|
|
HEK293
|
EC50 |
|
Agonist activity at mouse PPARgamma expressed in HEK293 cells co-expressing with Gal4 reporter vector after 24 hrs by dual-luciferase reporter assay
Agonist activity at mouse PPARgamma expressed in HEK293 cells co-expressing with Gal4 reporter vector after 24 hrs by dual-luciferase reporter assay
|
[PMID: 24955889]
|
|
HEK293
|
IC50 |
|
Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
|
[PMID: 18533708]
|
|
HEK293
|
IC50 |
|
Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay
Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay
|
[PMID: 20731357]
|
|
HEK293
|
IC50 |
|
Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in gadolinium-induced calcium entry after 30 mins by fluo-4 dye based fluorescence assay
Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in gadolinium-induced calcium entry after 30 mins by fluo-4 dye based fluorescence assay
|
[PMID: 30943030]
|
|
HEK293
|
IC50 |
|
Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
|
[PMID: 18533708]
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human HL60 cells after 48 hrs by CCK8 assay
|
[PMID: 29475587]
|
|
HT-1080
|
EC50 |
|
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay
|
[PMID: 12027739]
|
|
HT-1080
|
ED50 |
12.2 μg/mL
Compound: apigenin
|
Cytotoxicity against human HT1080 cells
Cytotoxicity against human HT1080 cells
|
[PMID: 7931367]
|
|
HT-22
|
EC50 |
|
Neuroprotective activity against glutamate-induced cell death in mouse HT-22 cells assessed as increase in cell viability after 24 hrs by EZ-Cytox assay
Neuroprotective activity against glutamate-induced cell death in mouse HT-22 cells assessed as increase in cell viability after 24 hrs by EZ-Cytox assay
|
[PMID: 32991171]
|
|
HT-29
|
IC50 |
|
Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition
Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition
|
[PMID: 34355179]
|
|
HeLa
|
EC50 |
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 12027739]
|
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells after 48 hrs by CCK8 assay
Antiproliferative activity against human HeLa cells after 48 hrs by CCK8 assay
|
[PMID: 29475587]
|
|
HeLa
|
IC50 |
6.092 μM
Compound: Apigenin
|
Cytotoxicity against human HeLa cells
Cytotoxicity against human HeLa cells
|
[PMID: 31784199]
|
|
HeLa
|
IC50 |
>= 10 μM
Compound: apigenin
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 19278239]
|
|
HeLa S3
|
IC50 |
|
Cytotoxicity against human HeLa S3 cells assessed as cell viability incubated for 48 hrs by microscopic analysis
Cytotoxicity against human HeLa S3 cells assessed as cell viability incubated for 48 hrs by microscopic analysis
|
[PMID: 35704432]
|
|
HepG2
|
IC50 |
70.18 μM
Compound: Apigenin
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 26896708]
|
|
Huh-7
|
CC50 |
|
Cytotoxicity against human Huh7.5.1 cells by MTT assay
Cytotoxicity against human Huh7.5.1 cells by MTT assay
|
[PMID: 22445328]
|
|
Huh-7
|
EC50 |
|
Antiviral activity against HCV genotype 2a J399LM in Human Huh7.5.1 replicon cells assessed as suppression of viral replication after 72 hrs by luciferase reporter gene assay
Antiviral activity against HCV genotype 2a J399LM in Human Huh7.5.1 replicon cells assessed as suppression of viral replication after 72 hrs by luciferase reporter gene assay
|
[PMID: 22445328]
|
|
Huh-7
|
EC50 |
|
Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
|
[PMID: 22445328]
|
|
Jurkat
|
IC50 |
|
Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method
Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method
|
[PMID: 30776692]
|
|
Jurkat
|
IC50 |
1.8 μM
Compound: Apigenin
|
Inhibition of chymotrypsin-like activity of purified human 20S proteasome expressed in human Jurkat cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 2 hrs by fluorescence based method
Inhibition of chymotrypsin-like activity of purified human 20S proteasome expressed in human Jurkat cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 2 hrs by fluorescence based method
|
[PMID: 30776692]
|
|
Jurkat
|
IC50 |
30 μg/mL
Compound: Apigenin
|
Growth inhibition of human Jurkat cells
Growth inhibition of human Jurkat cells
|
[PMID: 19026536]
|
|
Jurkat
|
IC50 |
6.7 μg/mL
Compound: Apigenin
|
Cytotoxicity against human Jurkat cells in presence and relative to TRAIL
Cytotoxicity against human Jurkat cells in presence and relative to TRAIL
|
[PMID: 19026536]
|
|
KB
|
ED50 |
7.4 μg/mL
Compound: NSC-83244
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 469554]
|
|
KB
|
ED50 |
> 20 μg/mL
Compound: apigenin
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 7931367]
|
|
KB-V1
|
ED50 |
16.8 μg/mL
Compound: apigenin
|
Cytotoxicity against human KBV1 cells
Cytotoxicity against human KBV1 cells
|
[PMID: 7931367]
|
|
L02
|
IC50 |
> 100 μM
Compound: Apigenin
|
Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
|
[PMID: 26896708]
|
|
L6
|
IC50 |
|
Cytotoxicity against rat L6 cells after 72 hrs by alamar blue staining based fluorescence analysis
Cytotoxicity against rat L6 cells after 72 hrs by alamar blue staining based fluorescence analysis
|
10.1039/C5MD00481K
|
|
L6
|
IC50 |
|
Antitrypanosomal activity against trypomastigote forms of Trypanosoma cruzi Tulahuen C2C4 infected in rat L6 cells after 96 hrs by photometric method
Antitrypanosomal activity against trypomastigote forms of Trypanosoma cruzi Tulahuen C2C4 infected in rat L6 cells after 96 hrs by photometric method
|
10.1039/C5MD00481K
|
|
Lu1
|
ED50 |
14 μg/mL
Compound: apigenin
|
Cytotoxicity against human Lu1 cells
Cytotoxicity against human Lu1 cells
|
[PMID: 7931367]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
|
[PMID: 33257172]
|
|
MCF7
|
IC50 |
|
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
MCF7
|
IC50 |
|
Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation
Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation
|
[PMID: 8784443]
|
|
MCF7
|
IC50 |
> 100 μM
Compound: apigenin
|
Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol
Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol
|
[PMID: 8784443]
|
|
MDCK
|
CC50 |
|
Cytotoxicity against MDCK cells by MTT assay
Cytotoxicity against MDCK cells by MTT assay
|
[PMID: 18640042]
|
|
MDCK
|
CC50 |
|
Cytotoxicity against MDCK cells after 48 hrs by MTT assay
Cytotoxicity against MDCK cells after 48 hrs by MTT assay
|
[PMID: 19729316]
|
|
MDCK
|
EC50 |
|
Antiviral activity against influenza A virus H9N2 A/Chicken/Korea/MS96/96 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
Antiviral activity against influenza A virus H9N2 A/Chicken/Korea/MS96/96 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
|
[PMID: 19729316]
|
|
MDCK
|
EC50 |
|
Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
|
[PMID: 19729316]
|
|
MDCK
|
IC50 |
|
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
MV4-11
|
GI50 |
|
Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay
Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay
|
[PMID: 23411073]
|
|
Monocyte
|
IC50 |
1.2 x 10 -6 M
Compound: apigenin
|
Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
|
[PMID: 8882428]
|
|
Monocyte
|
IC50 |
|
Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
|
[PMID: 10096854]
|
|
N9
|
IC50 |
|
Inhibitory effect of compound on the accumulation of NO2 in the culture media of N9 cells in response to LPS/IFN-gamma
Inhibitory effect of compound on the accumulation of NO2 in the culture media of N9 cells in response to LPS/IFN-gamma
|
[PMID: 15013012]
|
|
NCI/ADR-RES
|
IC50 |
|
Cytotoxicity against human MCF7ADR cells
Cytotoxicity against human MCF7ADR cells
|
[PMID: 37847948]
|
|
Neutrophil
|
IC50 |
|
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of HOCl-induced oxidation of APF after 6 mins by fluorescence assay
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of HOCl-induced oxidation of APF after 6 mins by fluorescence assay
|
[PMID: 23871908]
|
|
Neutrophil
|
IC50 |
|
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of H2O2-induced oxidation of amplex red incubated for 5 mins prior to PMA challenge by fluorescence assay
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of H2O2-induced oxidation of amplex red incubated for 5 mins prior to PMA challenge by fluorescence assay
|
[PMID: 23871908]
|
|
Neutrophil
|
IC50 |
|
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of ROS-induced luminol oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of ROS-induced luminol oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay
|
[PMID: 23871908]
|
|
Neutrophil
|
IC50 |
|
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of superoxide anion radical-induced lucigenin oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of superoxide anion radical-induced lucigenin oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay
|
[PMID: 23871908]
|
|
P388
|
ED50 |
12.2 μg/mL
Compound: apigenin
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 7931367]
|
|
Peritoneal macrophage
|
IC50 |
|
Inhibition of LPS-stimulated nitric oxide production in ddy mouse peritoneal macrophages measured after 20 hrs by Greiss method
Inhibition of LPS-stimulated nitric oxide production in ddy mouse peritoneal macrophages measured after 20 hrs by Greiss method
|
[PMID: 27955927]
|
|
RAW
|
IC50 |
|
Inhibitory effect of compound on the accumulation of NO2 in the culture media of RAW 264.7 cells in response to LPS
Inhibitory effect of compound on the accumulation of NO2 in the culture media of RAW 264.7 cells in response to LPS
|
[PMID: 15013012]
|
|
RAW264.7
|
CC50 |
|
Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 33667099]
|
|
RAW264.7
|
IC50 |
0.5 μM
Compound: apigenin
|
Inhibition of COX2 protein expression in mouse RAW264.7 cells
Inhibition of COX2 protein expression in mouse RAW264.7 cells
|
[PMID: 16038536]
|
|
RAW264.7
|
IC50 |
12.16 μM
Compound: 25; 37
|
Anti-inflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production
Anti-inflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production
|
[PMID: 37683361]
|
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
|
[PMID: 31747281]
|
|
RAW264.7
|
IC50 |
|
Inhibition of LPS/INF-gamma-stimulated nitric oxide production in mouse RAW264.7 cells measured after 16 hrs
Inhibition of LPS/INF-gamma-stimulated nitric oxide production in mouse RAW264.7 cells measured after 16 hrs
|
[PMID: 27955927]
|
|
RAW264.7
|
IC50 |
|
Inhibition of LPS induced NO production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay
Inhibition of LPS induced NO production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay
|
[PMID: 33667099]
|
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs by Griess reagent method
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs by Griess reagent method
|
[PMID: 19778086]
|
|
RAW264.7
|
IC50 |
7.7 μM
Compound: Apigenin
|
Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
|
[PMID: 20363145]
|
|
RBL-2H3
|
IC50 |
|
Antihistaminic activity in rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced beta-hexosaminidase release preincubated for 10 mins before DNP-BSA challenge
Antihistaminic activity in rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced beta-hexosaminidase release preincubated for 10 mins before DNP-BSA challenge
|
[PMID: 14510616]
|
|
RS4-11
|
GI50 |
|
Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay
Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay
|
[PMID: 23411073]
|
|
SK-MEL-2
|
ED50 |
13.6 μg/mL
Compound: apigenin
|
Cytotoxicity against human SK-MEL-2 cells
Cytotoxicity against human SK-MEL-2 cells
|
[PMID: 7931367]
|
|
THP-1
|
IC50 |
|
Cytotoxicity against human THP1 cells after 24 hrs by MTS assay
Cytotoxicity against human THP1 cells after 24 hrs by MTS assay
|
[PMID: 19879672]
|
|
Vero
|
CC50 |
54 μg/mL
Compound: apigenin
|
Cytotoxicity against african green monkey Vero cells
Cytotoxicity against african green monkey Vero cells
|
[PMID: 1338212]
|